Associations between frailty, physical performance, and renal biomarkers in older people with advanced chronic kidney disease.

Autor: Smith G; AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK., Avenell A; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Band MM; Tayside Clinical Trials Unit, University of Dundee, Dundee, UK., Hampson G; Department of Clinical Chemistry and Metabolic Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK., Lamb EJ; Pathology Department, East Kent Hospitals University NHS Foundation Trust, Canterbury, UK., Littleford RC; University of Queensland, Brisbane, QLD, Australia., McNamee P; Health Economics Research Unit, University of Aberdeen, Aberdeen, UK., Soiza RL; Ageing Clinical and Experimental Research, University of Aberdeen, Aberdeen, UK., Sumukadas D; Department of Medicine for the Elderly, NHS Tayside, Dundee, UK., Witham MD; AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK. Miles.Witham@newcastle.ac.uk.
Jazyk: angličtina
Zdroj: European geriatric medicine [Eur Geriatr Med] 2021 Oct; Vol. 12 (5), pp. 943-952. Date of Electronic Publication: 2021 Mar 17.
DOI: 10.1007/s41999-021-00478-4
Abstrakt: Purpose: Impaired physical performance and frailty are common in older people with advanced chronic kidney disease but it is unclear which metabolic derangements contribute to these impairments. We, therefore, examined associations between renal biochemical markers and both physical performance and frailty in older people with advanced chronic kidney disease.
Methods: Secondary analysis of data from the BiCARB trial, which enrolled non-dialysing patients aged 60 and over, with chronic kidney disease stage 4/5, with serum bicarbonate < 22 mmol/L. Participants undertook the Short Physical Performance Battery, maximum grip strength and six-minute walk test at baseline, 3, 6, 12 and 24 months. Renal biochemistry (serum creatinine, cystatin C, phosphate, and bicarbonate), haemoglobin, 25-hydroxyvitamin D and NT-pro-B-type natriuretic peptide were measured at baseline. Associations between baseline renal biochemistry and physical performance, and between baseline biochemistry and the monthly rate of change in physical performance were assessed.
Results: We analysed data from 300 participants (mean age 74 years; 86 [29%] women). 148 (49%) were pre-frail, 86 (29%) were frail. In multivariable cross-sectional baseline analyses, only age and BMI were significantly associated with baseline short physical performance battery; age, sex, body mass index, NT-pro-BNP and 25-hydroxyvitamin D were significantly associated with baseline six-minute walk distance. No significant associations were found between biochemical markers and change in physical performance over time, except between baseline 25-hydroxyvitamin D concentration and change in six-minute walk distance.
Conclusions: Biochemical markers associated with chronic kidney disease did not consistently associate with baseline physical performance or the rate of change of physical performance measures.
Trial Registration: ISRCTN09486651.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz: